Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Journal of the National Cancer Institute. Monographs|June 12, 2015
Early Surrogate Markers of Treatment Activity: Where Are We Now?Marie Klintman, Mitchell DowsettJournal of the National Cancer Institute|September 2, 2017
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast CancerAndreas Heindl, Ivana Sestak, Kalnisha Naidoo, et al.Anticancer Research|August 15, 2002
Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifenNigel J Bundred, Elizabeth Anderson, Robert I Nicholson, et al.International Journal of Oncology|July 13, 2005
Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complexBin Chen, Csaba Gajdos, Rita Dardes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapyMarina Parton, Stanislaw Krajewski, Ian Smith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2010
Biological evidence for dual antiangiogenic-antiaromatase activity of the VEGFR inhibitor PTK787/ZK222584 in vivoSusana Banerjee, Roger A'Hern, Simone Detre, et al.Breast Cancer Research and Treatment|July 2, 2008
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.Breast Cancer Research and Treatment|February 28, 2009
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancerZara Ghazoui, Francesca M Buffa, Anita K Dunbier, et al.Breast Cancer Research and Treatment|July 13, 2016
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trialsAdam R Brentnall, Jack Cuzick, Helen Byers, et al.Pageof 5